A selection of normal prostate and prostatic adenocarcinoma samples included in the database reveal a similar range of distributions, but there is not enough information to determine whether a specific subcellular location of GPR158 might associate with tumorigenesis or progression to CRPC. This evidence concerns the gene GPR158 and prostate adenocarcinoma.